MedPath

CAMURUS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

TGA:8

Drug Approvals

BUVIDAL MONTHLY buprenorphine 160 mg/0.45 mL modified release solution for injection (341073)

Product Name
BUVIDAL MONTHLY buprenorphine 160 mg/0.45 mL modified release solution for injection
Approval Date
Apr 30, 2021
TGA

BUVIDAL MONTHLY buprenorphine 64 mg/0.18 mL modified release solution for injection (295045)

Product Name
BUVIDAL MONTHLY buprenorphine 64 mg/0.18 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

BUVIDAL MONTHLY buprenorphine 128 mg/0.36 mL modified release solution for injection (295051)

Product Name
BUVIDAL MONTHLY buprenorphine 128 mg/0.36 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

BUVIDAL WEEKLY buprenorphine 16 mg/0.32 mL modified release solution for injection (295010)

Product Name
BUVIDAL WEEKLY buprenorphine 16 mg/0.32 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

BUVIDAL WEEKLY buprenorphine 24 mg/0.48 mL modified release solution for injection (295013)

Product Name
BUVIDAL WEEKLY buprenorphine 24 mg/0.48 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

BUVIDAL WEEKLY buprenorphine 8 mg/0.16 mL modified release solution for injection (294997)

Product Name
BUVIDAL WEEKLY buprenorphine 8 mg/0.16 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

BUVIDAL WEEKLY buprenorphine 32 mg/0.64 mL modified release solution for injection (295042)

Product Name
BUVIDAL WEEKLY buprenorphine 32 mg/0.64 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection (295048)

Product Name
BUVIDAL MONTHLY buprenorphine 96 mg/0.27 mL modified release solution for injection
Approval Date
Nov 28, 2018
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.